References
- Mikhailidis D P., Barradas M A., Mier A, et al. Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology 1987; 38: 36–45
- Sherman C T., Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913–919
- Robertson R M., Robertson D, Timmons S, et al. Platelet aggregates in peripheral and coronary sinus blood in patients with spontaneous coronary artery spasm. Lancet 1980; 2: 829–831
- Moncada S, Vane J R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978; 34: 129–135
- Ubatuba F B., Moncada S, Vane J R. The effect of prostacyclin (PGI2) on platelet behaviour, thrombus formation in vivo and bleeding time. Thromb Haemost 1979; 41: 425–434
- Henriksson P, Wennmalm A, Edhag O, et al. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. Br Heart J 1986; 55: 543–548
- Vesterquist O, Edhag O, Green K, Henriksson P. In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. Thromb Res 1985; 37: 459–464
- Mehta P, Mehta J. Platelet function studies in coronary heart disease. Thromb Res 1980; 18: 273–217, VIIIDecreased platelet sensitivity to prostacyclin in patients with myocardial ischaemia
- Mueller H S., Rao P S., Greenberg M A., et al. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin. Circulation 1985; 72: 1336–1345
- Born G. V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
- Heptinstall S, Mulley G P., Taylor P M., et al. Platelet release reaction in myocardial infarction. BMJ 1980, i: 80–81
- Hughes A, Daunt S, Vass G, et al. In vivo platelet activation following myocardial infarction and acute coronary ischaemia. Thromb Haemost 1982; 48: 133–135
- Nidorf S M., Sturm M, Strophair J, et al. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. Cardiovasc Res 1989; 23: 273–278
- Tofler G F., Brezinski D, Schafler A I., et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514–1518
- Knudsen J B., Gormsen J, Snagen K, et al. Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction. Thromb Haemost 1979; 42: 1513–1522
- McDaniel H G., Maddox W T., Poon M C. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction. Am J Cardiol 1983; 52: 965–968
- Trip M D., Cats V M., Capelle F. J.L., et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N End J Med 1990; 322: 1551–1554
- D'Angelo V, Villa S, Mysliewiec M, et al. Defective fibrinolytic and prostacyclin-like activity of human atheromatous plaques. Thromb Haemost 1978; 39: 535–536
- Mehta J, Mehta P. Role of blood platelets and prostaglandins in coronary artery disease. Am J Cardiol 1981; 48: 366–373
- Fitzgerald D J., Roy L, Catella F, et al. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–989
- Reilly IA G, Doran J B., Smith B, et al. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 1986; 73: 1300–1309
- Walinsky P, Smith J B., Lefer A M., et al. Thromboxane A, in acute myocardial infarction. Am Heart J 1984; 106: 868–872
- Tselepis A D., Tsoukatos D, Droudes C, et al. Platelet response to the aggregatory effect of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarction. Eur J Clin Invest 1991; 21: 490–496
- Moncada S, Vane J R. Arachidonic acid metabolism and the interactions between platelets and blood vessel walls. N Engl J Med 1979; 300: 1142–1147